NCT06146881View on ClinicalTrials.gov

Effectiveness of Diquafosol Prophylactic Therapy to Prevent Dry Eye Disease for Cataract Surgery Patients in Indonesia

PHASE2RecruitingINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

October 2, 2022

Primary Completion Date

December 15, 2023

Study Completion Date

March 15, 2024

Conditions
Dry Eye Disease
Interventions
DRUG

Diquafosol sodium 3%

Diquafosol sodium 3% 4 times a day for 4 weeks before cataract surgery and 21 days after surgery

DRUG

Sodium hyaluronate 0.1%

Sodium hyaluronate 0.1% 4 times a day for 4 weeks before cataract surgery and 21 days after surgery

Trial Locations (1)

10430

RECRUITING

RSUPN Dr. Cipto Mangunkusumo, Jakarta Pusat

All Listed Sponsors
collaborator

Santen Pharmaceutical Co., Ltd.

INDUSTRY

lead

Indonesia University

OTHER